Home > Insider Trading > Filing (0000912282-25-000188)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1509261	Rezolute Inc.	RZLT	Pharmaceutical Preparations (2834)	273440894

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1755074	Wladimir Hogenhuis	C/O Rezolute, Inc. 275 Shoreline Drive, Suite 500 Redwood City CA 94065		No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Shares	Acquisiton	2025-02-16	25,500	$0.00	67,267	No	4	A	Direct
Common Shares	Acquisiton	2025-02-18	10,000	$4.70	77,267	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	A	Direct
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Shares	Director Stock Option (Right to Buy)	Acquisiton	2025-02-16	15,000	$0.00	15,000	$4.61

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
15,000		2035-02-16	No	4	A	Direct

Footnotes

Represents grant of restricted stock units which vest 100% on March 1, 2026.
The options vest 100% on March 1, 2026.
The purchase price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.69 to $4.70, inclusive. The reporting person undertakes to provide to Rezolute, Inc., any security holder of Rezolute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.